From: Stock Gumshoe<travis@stockgumshoe.com>
Subject: What's being teased by Tom Gardner for Motley Fool Stock Advisor?
Preheader: Looking into his latest "under-the-radar stock"
Reply: travis@stockgumshoe.com
You're receiving this email newsletter because you, or someone
using newsletter@newslettercollector.com, signed up for the Stock Gumshoe Daily Update
 
Please unsubscribe if you don't want Stock Gumshoe emails
(this will not cancel membership, just stop emails). 

DAILY UPDATE
September 10, 2018
email formatted funny? Web version
Dear Valued Reader,

We've had a bunch of Motley Fool teaser questions this week, so we'll start with a look at one of them -- a tout from Tom Gardner himself, who says he's betting $523,111 on one stock that he thinks "could be one of the greatest discoveries of my 25 years as a professional investor."  That's pretty heavy, right?  What's the stock?  Just click below to...


In the first two months after California dispensaries started to legally sell recreational marijuana on January 1, companies in the cannabis industry increased by nearly $2 billion in value. And now Canada is set to legalize recreational marijuana by this Fall. Savvy investors are already grabbing positions in these 3 picks that are set to soar once the announcement is made.


Advertisement

Last  week we got things going with a blustery promise from Dr. Kent Moors that he has found "The Motherlode" in the desert and that somehow this entitles you to a piece of $1.4 trillion... sounds nice, right?  Our story and explanation is here.

After that we moved on to an even more ambitious promise:  Ray Blanco said he found the company that promises "no more diseases" and that the world would "stand still" when they announce their results on Wednesday morning.  Spoiler alert:  The world was profoundly unmoved when the news was announced the next day... but it's still an interesting story, you can see that one here.

Then it was on to another disease stopper -- this one an encore presentation of an Ernie Tremblay teaser solution, a $7 prostate cancer fighter... that story is here.

E.B. Tucker over at Casey's Strategic Investor newsletter is talking up "Bailout Compensation Checks" and making us think that thousand-dollar checks are on the way if we just learn the secret to signing up.  What's the real story?  Thinkolator results here.

And for the Irregulars' Friday File this week I've got a sale to note thanks to a stop loss, and a stop loss that I'm ignoring that you should also think about -- plus we had some huge quarters from Okta and FIVE to close out the week, which is fun to talk about, and news from Markel and a couple other companies as well... just click below:


Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
Unsubscribe
Stock Gumshoe, 351 Pleasant St., Suite B #205, Northampton, MA 01060